Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genelux (GNLX) Common Equity (2022 - 2025)

Genelux has reported Common Equity over the past 4 years, most recently at $11.5 million for Q4 2025.

  • Quarterly results put Common Equity at $11.5 million for Q4 2025, down 56.06% from a year ago — trailing twelve months through Dec 2025 was $11.5 million (down 56.06% YoY), and the annual figure for FY2025 was $11.5 million, down 56.06%.
  • Common Equity for Q4 2025 was $11.5 million at Genelux, down from $18.6 million in the prior quarter.
  • Over the last five years, Common Equity for GNLX hit a ceiling of $37.7 million in Q2 2024 and a floor of -$35.8 million in Q4 2022.
  • Median Common Equity over the past 4 years was $20.9 million (2023), compared with a mean of $14.0 million.
  • Biggest five-year swings in Common Equity: soared 460.54% in 2024 and later plummeted 56.06% in 2025.
  • Genelux's Common Equity stood at -$35.8 million in 2022, then surged by 154.42% to $19.5 million in 2023, then surged by 34.93% to $26.3 million in 2024, then plummeted by 56.06% to $11.5 million in 2025.
  • The last three reported values for Common Equity were $11.5 million (Q4 2025), $18.6 million (Q3 2025), and $23.9 million (Q2 2025) per Business Quant data.